Planning Directions Inc Abb Vie Inc. Transaction History

Planning Directions Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 25, 2019	SELL	$62.98 - $75.72 $234,915 - $282,435	-3,730 Closed	0 $0
Q2 2019 Jul 15, 2019	BUY	$65.7 - $83.98 $8,541 - $10,917	130 Added 3.61%	3,730 $271,000
Q1 2019 Apr 03, 2019	SELL	$77.14 - $90.79 $22,370 - $26,329	-290 Reduced 7.46%	3,600 $290,000
Q4 2018 Jan 16, 2019	BUY	$77.85 - $96.01 $9,809 - $12,097	126 Added 3.35%	3,890 $359,000
Q3 2018 Oct 05, 2018	BUY	$88.91 - $98.84 $24,094 - $26,785	271 Added 7.76%	3,764 $356,000
Q2 2018 Sep 05, 2018	BUY	$89.78 - $106.23 $32,949 - $38,986	367 Added 11.74%	3,493 $324,000
Q1 2018 May 10, 2018	BUY	$92.01 - $123.21 $287,623 - $385,154	3,126 New	3,126 $296,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Planning Directions Inc, based on Form 13F filings with the SEC.

Stay updated on Planning Directions Inc with notifications on news.